Balyasny Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.3M | Sell |
230,934
-538,809
| -70% | -$10M | 0.01% | 940 |
|
|
2025
Q1 | $14.7M | Buy |
+769,743
| New | +$14.7M | 0.02% | 537 |
|
|
2024
Q3 | – | Sell |
-8,629
| Closed | -$348K | – | 2363 |
|
|
2024
Q2 | $348K | Sell |
8,629
-225,891
| -96% | -$9.1M | ﹤0.01% | 1566 |
|
|
2024
Q1 | $8.3M | Buy |
234,520
+128,111
| +120% | +$4.54M | 0.01% | 735 |
|
|
2023
Q4 | $3.15M | Buy |
+106,409
| New | +$3.15M | 0.01% | 915 |
|
|
2023
Q2 | – | Sell |
-280,192
| Closed | -$11.4M | – | 2306 |
|
|
2023
Q1 | $11.4M | Sell |
280,192
-300,703
| -52% | -$12.2M | 0.03% | 570 |
|
|
2022
Q4 | $26.1M | Buy |
580,895
+287,375
| +98% | +$12.9M | 0.07% | 295 |
|
|
2022
Q3 | $14M | Buy |
+293,520
| New | +$14M | 0.04% | 444 |
|
|
2022
Q2 | – | Sell |
-102,891
| Closed | -$12M | – | 2700 |
|
|
2022
Q1 | $12M | Sell |
102,891
-68,587
| -40% | -$7.98M | 0.04% | 492 |
|
|
2021
Q4 | $25.8M | Buy |
+171,478
| New | +$25.8M | 0.09% | 264 |
|
|
2020
Q4 | – | Sell |
-285,720
| Closed | -$32.4M | – | 1478 |
|
|
2020
Q3 | $32.4M | Buy |
285,720
+131,026
| +85% | +$14.9M | 0.24% | 89 |
|
|
2020
Q2 | $15.3M | Sell |
154,694
-2,849
| -2% | -$282K | 0.13% | 204 |
|
|
2020
Q1 | $10.1M | Sell |
157,543
-251,471
| -61% | -$16.2M | 0.12% | 207 |
|
|
2019
Q4 | $24.4M | Buy |
409,014
+191,161
| +88% | +$11.4M | 0.15% | 203 |
|
|
2019
Q3 | $12.8M | Sell |
217,853
-39,240
| -15% | -$2.31M | 0.09% | 314 |
|
|
2019
Q2 | $16.6M | Buy |
257,093
+252,928
| +6,073% | +$16.3M | 0.11% | 234 |
|
|
2019
Q1 | $264K | Sell |
4,165
-82,270
| -95% | -$5.21M | ﹤0.01% | 1215 |
|
|
2018
Q4 | $3.28M | Buy |
86,435
+27,462
| +47% | +$1.04M | 0.02% | 518 |
|
|
2018
Q3 | $2.53M | Sell |
58,973
-356,027
| -86% | -$15.2M | 0.01% | 724 |
|
|
2018
Q2 | $9.14M | Buy |
415,000
+127,500
| +44% | +$2.81M | 0.04% | 431 |
|
|
2018
Q1 | $1.43M | Buy |
+287,500
| New | +$1.43M | 0.01% | 916 |
|